Adiponectin, an adipocyte‐derived hormone, ameliorates the aberrant expression of the Bmal1 mRNA/protein induced by Aβ31‐35 via inhibition of GSK3β activity, and exogenous administration of adiponectin may be a promising treatment for AD (Yuan et al., 2021). Here, BMAL1 is linked to Alzheimer disease.